Showing results (531-540 of 753) with videos related to
Sort By:
Pageof 76
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 7, 2006
Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomibPaul G Richardson, Hannah Briemberg, Sundar Jagannath, et al.The Lancet. Oncology|November 8, 2015
Immunotherapy response assessment in neuro-oncology: a report of the RANO working groupHideho Okada, Michael Weller, Raymond Huang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2023
Depth of Radiographic Response and Time to Tumor Regrowth Predicts Overall Survival Following Anti-VEGF Therapy in Recurrent GlioblastomaBenjamin M Ellingson, Akifumi Hagiwara, Connor J Morris, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Phase I trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium StudyTimothy F Cloughesy, John Kuhn, H Ian Robins, et al.Nature Biotechnology|November 8, 2016
Drug sensitivity of single cancer cells is predicted by changes in mass accumulation rateMark M Stevens, Cecile L Maire, Nigel Chou, et al.International Journal of Radiation Oncology, Biology, Physics|April 6, 2015
Hypofractionated versus standard radiation therapy with or without temozolomide for older glioblastoma patientsNils D Arvold, Shyam K Tanguturi, Ayal A Aizer, et al.The Lancet. Oncology|September 30, 2021
Leveraging external data in the design and analysis of clinical trials in neuro-oncologyRifaquat Rahman, Steffen Ventz, Jon McDunn, et al.Neuro-Oncology|April 4, 2017
Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomasMatthias Holdhoff, Xiaobu Ye, Jeffrey G Supko, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2015
Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System LymphomasEsteban Braggio, Scott Van Wier, Juhi Ojha, et al.Neuro-Oncology|August 8, 2014
Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningiomaThomas J Kaley, Patrick Wen, David Schiff, et al.Pageof 76